Paolo Tarantino shared a post on X:
“ADCs bring us together in the fight against cancer, irrespective of its site of origin.
Learned a lot from this conversation on ADC toxicities with Benjamin Levy, wonderfully chaired by Narjust Florez.
Podcast episode here.”
Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.